A carregar...
Omalizumab as an adjuvant therapy for treating severe atopic dermatitis in children. A serie of cases
Background: Atopic dermatitis (AD) is a chronic skin disease that affects 5-20% of children. This disease compromises the quality of life. Omalizumab offers a promising role in the treatment of severe atopic dermatitis.Objective: To share our experience with the use of omalizumab for treating severe...
Na minha lista:
| Publicado no: | Revista Alergia México |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Colegio Mexicano de Inmunología Clínica y Alergia, A.C.
2019
|
| Assuntos: | |
| Acesso em linha: | https://www.redalyc.org/articulo.oa?id=486761439003 https://www.redalyc.org/journal/4867/486761439003/ https://www.redalyc.org/journal/4867/486761439003/html/ https://www.redalyc.org/journal/4867/486761439003/486761439003.epub https://www.redalyc.org/journal/4867/486761439003/movil |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|